Home
TLX
TLX News

Latest Telix Pharmaceuticals Limited American Depositary Shares (TLX) News on July 13, 2025

Telix Pharmaceuticals (TLX) Announces That US FDA Approves Label Expansion for Illuccix

Insider Monkey

13 days ago

Telix Pharmaceuticals (TLX) Announces That US FDA Approves Label Expansion for Illuccix

Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT

GlobeNewswire

20 days ago

Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT

Pro Medicus And 2 Other High Growth Tech Stocks In Australia

Simply Wall St.

20 days ago

Pro Medicus And 2 Other High Growth Tech Stocks In Australia

Telix Precision Medicine Announces AlFluor Radiochemistry Platform

GlobeNewswire

23 days ago

Telix Precision Medicine Announces AlFluor Radiochemistry Platform

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

GlobeNewswire

23 days ago

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

ASX Growth Stocks With High Insider Ownership To Watch

Simply Wall St.

24 days ago

ASX Growth Stocks With High Insider Ownership To Watch

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

GlobeNewswire

a month ago

Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

Telix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer Detection

Simply Wall St.

a month ago

Telix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer Detection

Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan

PR Newswire

a month ago

Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan

Telix Investor Day in New York City on June 11, 2025: Presenting KOLs

GlobeNewswire

a month ago

Telix Investor Day in New York City on June 11, 2025: Presenting KOLs

Telix to Host Investor Day in New York City on June 11, 2025

GlobeNewswire

2 months ago

Telix to Host Investor Day in New York City on June 11, 2025

Catapult Group International And 2 Other High Growth Tech Stocks In Australia

Simply Wall St.

2 months ago

Catapult Group International And 2 Other High Growth Tech Stocks In Australia

ASX Growth Companies With Strong Insider Ownership May 2025

Simply Wall St.

2 months ago

ASX Growth Companies With Strong Insider Ownership May 2025

Telix at ANZSNM Annual Scientific Meeting 2025

PR Newswire

2 months ago

Telix at ANZSNM Annual Scientific Meeting 2025

A Note On Telix Pharmaceuticals Limited's (ASX:TLX) ROE and Debt To Equity

Simply Wall St.

2 months ago

A Note On Telix Pharmaceuticals Limited's (ASX:TLX) ROE and Debt To Equity

Illuccix China Phase 3 Study Completes Enrolment

PR Newswire

2 months ago

Illuccix China Phase 3 Study Completes Enrolment

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

PR Newswire

2 months ago

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

GlobeNewswire

2 months ago

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

PR Newswire

2 months ago

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix Reports US$186M Q1 Revenue, Up 62% YOY

GlobeNewswire

3 months ago

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

Benzinga

3 months ago

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

PR Newswire

3 months ago

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy

Zacks

3 months ago

All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy

Telix Announces Cardinal Health for Gozellix Commercial Distribution

GlobeNewswire

3 months ago

Telix Announces Cardinal Health for Gozellix Commercial Distribution

Telix Appoints Paul Schaffer as Chief Technology Officer

GlobeNewswire

3 months ago

Telix Appoints Paul Schaffer as Chief Technology Officer

Anne Whitaker Appointed as Non-Executive Director

GlobeNewswire

3 months ago

Anne Whitaker Appointed as Non-Executive Director

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

GlobeNewswire

3 months ago

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®

GlobeNewswire

3 months ago

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

GlobeNewswire

4 months ago

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

PR Newswire

4 months ago

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Telix Adds Lead-212 Isotope Production Capability

PR Newswire

4 months ago

Telix Adds Lead-212 Isotope Production Capability

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

PR Newswire

4 months ago

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

PR Newswire

5 months ago

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami

GlobeNewswire

5 months ago

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami

Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

5 months ago

Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?

GuruFocus.com

5 months ago

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ...

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

PR Newswire

5 months ago

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)

GlobeNewswire

5 months ago

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)

Illuccix® Approved in the United Kingdom

GlobeNewswire

5 months ago

Illuccix® Approved in the United Kingdom

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

Insider Monkey

5 months ago

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

PR Newswire

5 months ago

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Telix Completes Acquisition of RLS (USA) Inc.

GlobeNewswire

6 months ago

Telix Completes Acquisition of RLS (USA) Inc.

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

PR Newswire

6 months ago

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

Illuccix® Receives European Approval

PR Newswire

6 months ago

Illuccix® Receives European Approval

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

6 months ago

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

PR Newswire

6 months ago

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

Scintimun® Commercialization Partnership with Curium Pharma

PR Newswire

6 months ago

Scintimun® Commercialization Partnership with Curium Pharma

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

PR Newswire

6 months ago

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

PR Newswire

6 months ago

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

PR Newswire

6 months ago

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

GlobeNewswire

6 months ago

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

GlobeNewswire

7 months ago

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

PR Newswire

7 months ago

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

Share on Social Networks: